V019-6025 Screening compound: 3-(4-chlorophenyl)-5-[3-methyl-4-(3-thienylmethyl)piperazino][1,2,4]triazolo[4,3-c]quinazoline

V019-6025 Screening compound: 3-(4-chlorophenyl)-5-[3-methyl-4-(3-thienylmethyl)piperazino][1,2,4]triazolo[4,3-c]quinazoline
V019-6025 Screening compound: 3-(4-chlorophenyl)-5-[3-methyl-4-(3-thienylmethyl)piperazino][1,2,4]triazolo[4,3-c]quinazoline alternative view

Chemical Structure Depiction of ChemDiv screening compound V019-6025
3-(4-chlorophenyl)-5-[3-methyl-4-(3-thienylmethyl)piperazino][1,2,4]triazolo[4,3-c]quinazoline

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V019-6025

Molecular Formula

C25H23ClN6S (C25 H23 ClN6 S)

Compound Name

3-(4-chlorophenyl)-5-[3-methyl-4-(3-thienylmethyl)piperazino][1,2,4]triazolo[4,3-c]quinazoline

IUPAC name

4-[3-(4-chlorophenyl)-[124]triazolo[43-c]quinazolin-5-yl]-2-methyl-1-[(thiophen-3-yl)methyl]piperazine

SMILES

CC(C1)N(Cc2cscc2)CCN1c1nc(cccc2)c2c2nnc(-c(cc3)ccc3Cl)n12

InChI

InChI=1S/C25H23ClN6S/c1-17-14-31(12-11-30(17)15-18-10-13-33-16-18)25-27-22-5-3-2-4-21(22)24-29-28-23(32(24)25)19-6-8-20(26)9-7-19/h2-10,13,16-17H,11-12,14-15H2,1H3/t17-/m0/s1

InChI Key

WCGQHNRGJVEMKZ-KRWDZBQOSA-N

MDL Number (MFCD)

MFCD19924388

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

475.02

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.413

Distribution Coefficient, logD

4.106

Water Solubility, LogSw

-6.23

Polar Surface Area

36.936

Acid Dissociation Constant (pKa)

20.82

Base Dissociation Constant (pKb)

8.68

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

24.00

V019-6025 in Drug Discovery

Included in Screening Libraries

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
Targets:
  • GPCR
  • Ion Channels

References: we are preparing a list of scientific research reports with V019-6025 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V019-6025?
Check Price and Availability of V019-6025, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V019-6025 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V019-6025
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V019-6025
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V019-6025 available by request